Hims & Hers: The Odds Are In Your Favor, Here's How To Take Advantage (Rating Upgrade)
Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Cosmetics Business2d
Hims & Hers shutters dermatology business Apostrophe
Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...
Hims & Hers: A Generational Dip-Buying Opportunity
Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...
Fierce Healthcare17d
Hims & Hers projects weight loss business to hit $725M in 2025 despite GLP-1 market shift
Hims & Hers brought in $1.48 billion in revenue ... perimenopausal and menopausal support." The blood tests also can give the company data on hormone levels, cardiac risk, stress markers ...
Business Wire22d
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab testing through its platfor ...
NBC Bay Area23d
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
It will also expand the company's ability to offer access to care and treatments across a range of conditions including low testosterone and premenopausal and menopausal support. Hims users will ...
NBC New York23d
Hims & Hers to offer at-home blood draws, lean into ‘peptide innovations' with new acquisitions
It will also expand the company's ability to offer access to care and treatments across a range of conditions including low testosterone and perimenopausal and menopausal support. Hims & Hers ...